NASDAQ:EDSA | Free Cash Flow | Edesa Biotech, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-08-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$2.09M
2025-09-30-$1.72M
2024-12-31-$1.52M
2024-09-30-$967,039.00
2023-12-31-$1.41M
2023-09-30-$1.47M$0.00-$1.47M
2022-12-31-$1.79M$0.00-$1.79M
2022-09-30-$5.63M-$41.00-$5.63M
2021-12-31-$3.21M$3,140.00-$3.21M
2021-09-30-$355,321.00-$1,464.00-$356,785.00
2020-12-31-$3.01M$1,135.00-$3.01M
2020-09-30-$1.67M$4,031.00-$1.68M
2019-12-31-$789,712.00$0.00-$789,712.00
2018-12-31-$382,346.00$5,666.00-$388,012.00
2018-09-30-$971,233.00$21,410.00-$992,643.00
2017-12-31-$1.14M$34,767.00-$1.18M
2017-09-30-$1.12M$102,368.00-$1.22M
2016-12-31-$1.37M$84,424.00-$1.45M
2016-09-30-$1.19M$107,413.00-$1.3M
2015-12-31-$1.17M$175,019.00-$1.35M
2015-09-30-$915,102.00$71,592.00-$986,694.00
2014-12-31-$1.29M$38,849.00-$1.32M
2013-12-31-$1.09M$209,129.00-$1.3M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$7.32M
2024-09-30-$4.89M
2023-09-30-$6.64M$0.00-$6.64M
2022-09-30-$12.28M$5,656.00-$12.28M
2021-09-30-$13.66M$6,146.00-$13.67M
2020-09-30-$4.99M$4,856.00-$4.99M
2018-09-30-$4.62M$382,810.00-$5M
2017-09-30-$4.7M$302,733.00-$5M
2016-09-30-$4.51M$402,271.00-$4.91M
2015-09-30-$4.41M$274,589.00-$4.69M
2014-08-31-$4.27M$279,065.00-$4.55M
2013-08-31-$2.8M$9,541.00-$2.81M
2012-08-31-$3.95M$78,338.00-$4.03M